期刊文献+

TF、TFPI在胎盘早剥产妇中的表达水平及临床意义

Expression levels and clinical significance of TF and TFPI in placental abruption parturients
下载PDF
导出
摘要 目的:探讨组织因子(tissue factor,TF)、组织因子途径抑制物(tissue factor pathway inhibitor,TFPI)在胎盘早剥产妇中的表达水平及临床意义。方法:选择72例胎盘早剥产妇作为观察组,选择73例正常足月产妇作为对照组,均检测TF、TFPI水平,比较两组产妇的TF、TFPI表达水平。结果:观察组母血及脐血中TF水平[(89. 23±22. 18) ng/mg、(97. 23±28. 56) ng/mg]均高于对照组[(67. 45±10. 25) ng/mg、(63. 12±7. 13) ng/mg](P <0. 05);观察组母血及脐血中TFPI水平[(18. 25±7. 26) ng/mg、(19. 23±7. 58) ng/mg]均低于对照组[(26. 89±7. 16) ng/mg、(24. 23±7. 01) ng/mg](P <0. 05)。结论:TF、TFPI是体内重要的凝血及抗凝血因子,母血及脐血中TF、TFPI水平可作为胎盘早剥的参考指标。 Objective: To explore the expression levels and clinical significance of tissue factors (TF) and tissue factor pathway inhibitors (TFPI) in placental abruption parturients. Methods: 72 placental abruption parturients were selected as the observation group and 73 normal full-term parturients were selected as the control group, with the levels of TF and TFPI detected, and the expression levels of TF and TFPI in the two groups compared. Results: The levels of TF in maternal and umbilical blood of the observation group(89.23±22.18, 97.23±28.56)were higher than those of the control group(67.45±10.25, 63.12±7.13)( P 〈0.05). The levels of TFPI in maternal and umbilical blood of the observation group(18.25±7.26, 19.23±7.58)were lower than those of the control group(26.89±7.16、24.23±7.01)( P 〈0.05). Conclusion: TF and TFPI are important coagulation and anticoagulant factors in the body. The levels of TF and TFPI in maternal blood and umbilical cord blood can be used as the reference indexes for early placental abruption.
作者 康健明 钟颖芙 KANG Jianming;ZHONG Yingfu(Zhanjiang Maternal and Child Health Care and Family Planning Service Center,Guangdong Zhanjiang 524500,China)
出处 《包头医学院学报》 CAS 2018年第10期80-81,共2页 Journal of Baotou Medical College
关键词 胎盘早剥 组织因子 组织因子途径抑制物 表达水平 Placental abruption Tissue factor Tissue factor pathway inhibitor Expression level
  • 相关文献

参考文献3

二级参考文献26

  • 1Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes [ J ]. Obstet Gynecol, 2005,105 ( 2 ) : 239 - 245.
  • 2Cleary-Goldman J, Malone FD, Lambert-Messer|ian G, et al. Maternal thyroid hypofunction and pregnancy outcome [ J]. Obstet Gynecol, 2008,112( 1 ) :85 -92.
  • 3The American Thyroid Association Taskforce on Thyroid Disease Dur- ing Pregnancy and Postpartum. Guidelines of the american thyroid as- sociation for the diagnosis and management of thyroid disease during pregnancy and postpartum [ J ]. Thyroid, 2011,21 ( 10 ) : 1081 - 1125.
  • 4Negro R,Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy [ J ]. BMJ, 2014,349 ( 10 ) : g4929.
  • 5Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficien- cy and pregnancy complications:implications for population screening [ J ]. J Med Screen,2000,7 (3) : 127 - 130.
  • 6Negro R, Schwartz A, Gismondi R, et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy [ J ]. J Clin Endocrinol Metab,2010,95(9) :e44 - e48.
  • 7Thangm'atinam S, Tan A, Knox E, et al. Association between thyroid autoantbodies and miscarriage and preterm birth:meta-analysis of evi- dence[ J]. BMJ,2011,342(5) :d2616.
  • 8Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficien- cy during pregnancy and subsequent neuropsychological development of the child[J]. N Eng J Med,1999,341 (8) :549 -555.
  • 9Li Y, Shah Z, Teng W, et al. Abnormalities of maternal thyroid func- tion during pregnancy affect neuropsychological development of their children at 25-30 months [ J ]. Clin Endocrinol (Oxf) , 2010,72 ( 6 ) : 825 - 829.
  • 10Negro R, Schwartz A, Gismondi R,et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunc- tion during pregnancy [ J ]. J Clin Endocrinol Metab, 2010,95 ( 4 ) : 1699 - 1707.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部